CPHI
China Pharma Holdings Inc.
Halal Rating :
Last Price
$0.21
Last updated:
Market Cap
-
7D Change
2.58%
1 Year Change
125.57%
Company Overview
Industries
Exchange
Next Earnings Date
China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets generic and branded pharmaceutical products primarily to hospitals and private retailers in China. The company offers products in major therapeutic areas including cardiovascular, central nervous system, cerebral and neural disease, and infectious diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $1.1m | $2.22m | - | $34114.0 | 0.00% | 1.54% |
| June 30, 2024 | $924943.0 | $2.36m | - | $48140.0 | 0.00% | 2.04% |
| March 31, 2024 | $1.37m | $2.33m | - | $42155.0 | 0.00% | 1.81% |
Company Impact
Help us evaluate China Pharma Holdings Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.